| RS2135410340 |
PTS
|
Health Risk |
Pathogenic |
6-Pyruvoyl-tetrahydrobiopterin synthase deficiency, 6-Pyruvoyl-tetrahydrobiopterin synthase deficiency |
| RS2135410460 |
PTS
|
Health Risk |
Likely pathogenic |
6-Pyruvoyl-tetrahydrobiopterin synthase deficiency, 6-Pyruvoyl-tetrahydrobiopterin synthase deficiency |
| RS2135414009 |
INPPL1
|
Health Risk |
Likely pathogenic |
Opsismodysplasia, Opsismodysplasia |
| RS2135418994 |
SPTBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2135421164 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2135421507 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS2135421629 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135421772 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135421887 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135421905 |
PCDH15
|
Health Risk |
Pathogenic |
Usher syndrome type 1F, Autosomal recessive nonsyndromic hearing loss 23 |
| RS2135422280 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2135422352 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2135422402 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135422617 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2135424366 |
MYO7A
|
Health Risk |
Likely pathogenic |
— |
| RS2135426679 |
INPPL1
|
Health Risk |
Pathogenic |
— |
| RS2135426817 |
FANCC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Fanconi anemia |
| RS2135427018 |
FANCC
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2135428096 |
FANCC
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2135428273 |
FANCC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2135428776 |
C2CD3
|
Health Risk |
Pathogenic |
— |
| RS2135430236 |
MYO7A
|
Health Risk |
Pathogenic |
— |
| RS2135430894 |
MYO7A
|
Health Risk |
Pathogenic |
— |
| RS2135433834 |
COL27A1
|
Health Risk |
Likely pathogenic |
— |
| RS2135434002 |
COL27A1
|
Health Risk |
Pathogenic |
— |
| RS2135437164 |
NFKB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency, common variable |
| RS2135437962 |
DYNC2H1
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS2135438529 |
INPPL1
|
Health Risk |
Likely pathogenic |
Opsismodysplasia, Opsismodysplasia |
| RS2135440992 |
INPPL1
|
Health Risk |
Pathogenic |
— |
| RS2135442758 |
SLC22A12
|
Health Risk |
Pathogenic |
Dalmatian hypouricemia, Dalmatian hypouricemia |
| RS2135443636 |
NFKB2
|
Health Risk |
Pathogenic |
Immunodeficiency, common variable |
| RS2135445164 |
SLC22A12
|
Health Risk |
Pathogenic |
— |
| RS2135446720 |
INPPL1
|
Health Risk |
Likely pathogenic |
— |
| RS2135449650 |
INPPL1
|
Health Risk |
Pathogenic |
— |
| RS2135453120 |
COL27A1
|
Health Risk |
Pathogenic |
— |
| RS2135465268 |
MYO7A
|
Health Risk |
Pathogenic |
— |
| RS2135465689 |
PHF21A
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with behavioral abnormalities and craniofacial dysmorphism with or without seizures, Intellectual developmental disorder with behavioral abnormalities and craniofacial dysmorphism with or without seizures |
| RS2135467951 |
SPTBN2
|
Health Risk |
Pathogenic |
— |
| RS2135468678 |
CLMP
|
Health Risk |
Pathogenic |
— |
| RS2135472044 |
MYO7A
|
Health Risk |
Pathogenic |
— |
| RS2135473615 |
MYO7A
|
Health Risk |
Likely pathogenic |
Autosomal dominant nonsyndromic hearing loss 11, Autosomal recessive nonsyndromic hearing loss 2 |
| RS2135473984 |
MYO7A
|
Health Risk |
Likely pathogenic |
— |
| RS2135478294 |
MYO7A
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 11, Autosomal dominant nonsyndromic hearing loss 11 |
| RS2135478379 |
MYO7A
|
Health Risk |
Pathogenic |
— |
| RS2135484551 |
PHF21A
|
Health Risk |
Pathogenic |
— |
| RS2135484845 |
PHF21A
|
Health Risk |
Pathogenic |
— |
| RS2135485868 |
CLPB
|
Health Risk |
Pathogenic |
3-methylglutaconic aciduria, type VIIB |
| RS2135486189 |
MYO7A
|
Health Risk |
Pathogenic |
— |
| RS2135489647 |
FAM111A
|
Health Risk |
Likely pathogenic |
— |
| RS2135491492 |
SPTBN2
|
Health Risk |
Likely pathogenic |
— |
| RS2135493230 |
C2CD3
|
Health Risk |
Pathogenic/Likely pathogenic |
Orofaciodigital syndrome type 14, Orofaciodigital syndrome type 14 |
| RS2135493809 |
MYO7A
|
Health Risk |
Pathogenic |
— |
| RS2135494876 |
MYO7A
|
Health Risk |
Likely pathogenic |
— |
| RS2135495180 |
MYO7A
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 2, Autosomal recessive nonsyndromic hearing loss 2 |
| RS2135499848 |
MYO7A
|
Health Risk |
Likely pathogenic |
— |
| RS2135500473 |
CLPB
|
Health Risk |
Likely pathogenic |
3-methylglutaconic aciduria, type VIIB |
| RS2135500838 |
CLPB
|
Health Risk |
Pathogenic |
3-methylglutaconic aciduria, type VIIB |
| RS2135501951 |
EHMT1
|
Health Risk |
Pathogenic |
Kleefstra syndrome 1, Kleefstra syndrome 1 |
| RS2135504652 |
MYO7A
|
Health Risk |
Pathogenic |
— |
| RS2135505571 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135506851 |
ATM
|
Health Risk |
Pathogenic |
Gastric cancer, Gastric cancer |
| RS2135507457 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2135507546 |
ATM
|
Health Risk |
Pathogenic |
Gastric cancer, Ataxia-telangiectasia syndrome |
| RS2135507893 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2135508789 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135509419 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135509713 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2135510485 |
CLPB
|
Health Risk |
Pathogenic |
Neutropenia, severe congenital |
| RS2135511329 |
EHMT1
|
Health Risk |
Likely pathogenic |
— |
| RS2135511963 |
EHMT1
|
Health Risk |
Pathogenic |
Kleefstra syndrome 1, Kleefstra syndrome 1 |
| RS2135513350 |
EHMT1
|
Health Risk |
Pathogenic |
— |
| RS2135517143 |
MYO7A
|
Health Risk |
Likely pathogenic |
— |
| RS2135518421 |
MYO7A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1, Usher syndrome |
| RS2135522530 |
COL27A1
|
Health Risk |
Likely pathogenic |
— |
| RS2135522860 |
ATM
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135523450 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2135524751 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2135526204 |
SPTBN2
|
Health Risk |
Likely pathogenic |
Spinocerebellar ataxia type 5, Spinocerebellar ataxia type 5 |
| RS2135526299 |
SPTBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinocerebellar ataxia type 5, Spinocerebellar ataxia type 5 |
| RS2135527696 |
ATM
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Ataxia-telangiectasia syndrome |
| RS2135531602 |
COL27A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Steel syndrome, Steel syndrome |
| RS2135539546 |
ARCN1
|
Health Risk |
Likely pathogenic |
Short stature, rhizomelic |
| RS2135542081 |
ARCN1
|
Health Risk |
Pathogenic |
Short stature, rhizomelic |
| RS2135542758 |
ARCN1
|
Health Risk |
Likely pathogenic |
Short stature, rhizomelic |
| RS2135547107 |
ATM
|
Health Risk |
Likely pathogenic |
Breast carcinoma, Breast carcinoma |
| RS2135547194 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135547229 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135547839 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2135547909 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2135548845 |
RELA
|
Health Risk |
Pathogenic |
— |
| RS2135549026 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135549049 |
ATM
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135549951 |
RELA
|
Health Risk |
Pathogenic |
— |
| RS2135550200 |
MYO7A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 2, Autosomal recessive nonsyndromic hearing loss 2 |
| RS2135551484 |
ATM
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2135551778 |
NECTIN1
|
Health Risk |
Likely pathogenic |
Cleft lip/palate-ectodermal dysplasia syndrome, Cleft lip/palate-ectodermal dysplasia syndrome |
| RS2135552016 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2135552095 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135552199 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2135552390 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |